Pharma Journalist - Page 56 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

European Commission Approves DARZALEX as First Licensed Treatment for High-Risk Smouldering Multiple Myeloma

Gefurulimab Shows Significant Improvement in Daily Function for gMG Patients in Phase III PREVAIL Trial

Kling Bio and Sanofi Partner to Fast-Track Neutralizing Antibody Discovery

Sutro Biopharma Partners with FDA to Advance Antibody Drug Conjugate Regulatory Standards

Sanofi to Acquire Vicebio, Boosting Respiratory Vaccine Portfolio

ProMIS Neurosciences Receives FDA Fast Track Designation for PMN310 Alzheimer’s Treatment

AusperBio Secures China CDE Clearance to Launch Phase III Trial for AHB-137 in Chronic Hepatitis B

Sarepta Therapeutics Announces Voluntary Pause of ELEVIDYS Shipments in the U.S.

J&J Seeks First FDA Approval for Icotrokinra to Treat Plaque Psoriasis

AstraZeneca to Invest $50 Billion in U.S. for Drug Manufacturing and R&D